BIONIK (China) Medical Technology

BIONIK (China) Medical Technology Co., Ltd. is a joint venture established in 2017 between Bionik Laboratories Corp. and Ginger Capital Investment Holding Ltd. to commercialize advanced robotic rehabilitation solutions in the Chinese market. Headquartered in Tianjin, the company focuses on the distribution and clinical integration of the InMotion robotic systems, which are designed to assist patients with neurological and mobility challenges, particularly stroke survivors. The product portfolio includes the InMotion ARM, HAND, and WRIST systems, which utilize artificial intelligence and evidence-based interactive robotics to provide personalized, patient-adaptive therapy. The company also manages the regulatory approval process with the National Medical Products Administration (NMPA) to expand the reach of these technologies across China, Hong Kong, and Macau.